Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2014
03/13/2014WO2013156534A9 Cross-reactive staphylococcus aureus antibody
03/13/2014WO2013009521A9 Methods and compositions for treating asthma using anti-il-13 antibodies
03/13/2014WO2012127352A8 Mia (melanoma inhibitory activity) inhibitors for detecting, preventing and curing vitiligo
03/13/2014US20140075585 Tetraspanin CD82 as a Diagnostic and/or Therapeutic Module for Xenograft Recognition and/or Rejection
03/13/2014US20140073588 Glue composition for lung volume reduction
03/13/2014US20140073045 Mucin antigen vaccine
03/13/2014US20140072622 Vaccine against streptococcus pneumoniae
03/13/2014US20140072616 Lyophilization of Virosomes
03/13/2014US20140072597 Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase
03/13/2014US20140072596 Ex vivo, fast and efficient process to obtain activated antigen-presenting cells that are useful for therapies against cancer and immune system-related diseases
03/13/2014US20140072593 Method for suppressing an immune response
03/13/2014US20140072591 Ipn vaccine
03/13/2014US20140072590 Compositions and Methods for the Treatment or Prevention of Human Adenovirus-36 Infection
03/13/2014US20140072589 North American Porcine Reproductive and Respiratory Syndrome (PRRS) Virus and Uses Thereof
03/13/2014US20140072588 Absorption of therapeutic agents across mucosal membranes or the skin
03/13/2014US20140072584 Novel pharmaceutical use of benzoic acid derivatives
03/13/2014US20140072583 Methods for treating atopic dermatitis by administering an il-4r antagonist
03/13/2014US20140072580 Novel targets for treatment of hypercholesterolemia
03/13/2014US20140072574 Methods of using immunomodulating peptide for treating or preventing inflammatory related diseases
03/13/2014US20140072570 Antibodies or fragments thereof directed against a staphylococcus aureus epitope of isaa or isab
03/13/2014US20140072564 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
03/13/2014US20140072562 B-cell reduction using cd37-specific and cd20-specific binding molecules
03/13/2014US20140072559 Highly concentrated aqueous protein solution with reduced viscosity
03/13/2014US20140072558 Activin Receptor Type II B Inhibitors Comprising DLK1 Extracellular Water-Soluble Domain
03/13/2014US20140072555 Inhibitor Compounds and Cancer Treatment Methods
03/13/2014US20140072552 Composition of anti-endo180 antibodies and methods of use for the treatment of cancer and fibrotic diseases
03/13/2014US20140072528 Immunotherapy
03/13/2014US20140072511 Flt4 (vegfr-3) as a target for tumor imaging and anti-tumor therapy
03/12/2014EP2706116A1 Binding domain-immunoglobulin fusion proteins
03/12/2014EP2706070A1 Combination treatments involving antibodies to human PCSK9
03/12/2014EP2706041A1 Extracorporeal devices and methods of treating complications of pregnancy
03/12/2014EP2705854A1 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
03/12/2014EP2705853A1 Exopolysaccharide of shigella sonnei bacteria, method for producing same, vaccine and pharmaceutical composition containing same
03/12/2014EP2705852A1 An immunogenic composition against Staphylococcus aureus comprising an inactivated recombinant non-pathogenic bacterium
03/12/2014EP2705846A2 Methods for reducing allergies caused by environmental allergens
03/12/2014EP2705371A1 Identification of a new molecular factor for early diagnosis of urothelial carcinoma of the bladder
03/12/2014EP2705150A2 A synthetic hepatitis c genome and methods of making and use
03/12/2014EP2705058A1 Amino acid sequences directed against il-17a, il-17f and/or il17-a/f and polypeptides comprising the same
03/12/2014EP2704798A2 Formulation for anti- alpha4beta7 antibody
03/12/2014EP2704750A2 Tolerogenic synthetic nanocarriers for antigen-specific deletion of t effector cells
03/12/2014EP2704746A2 Methods for preventing toxic drug-drug interactions in combination therapies comprising anti-erbb3 agents
03/12/2014EP2704745A1 Methods of developing a prognosis for pancreatic cancer and predicting responsiveness to cancer therapeutics
03/12/2014EP2704744A1 Complement factor b analogs and their uses
03/12/2014EP2704743A1 Compositions for inhibiting masp-2 dependent complement acitivation
03/12/2014EP2704742A2 Formulation for anti- 4 7 antibody
03/12/2014EP2704741A1 Methods for handling biological drugs containing living cells
03/12/2014EP2704740A2 Inactivated swine flu virus and methods of preparing it
03/12/2014EP2704739A1 Recombinant immunotoxin targeting mesothelin
03/12/2014EP2704735A1 Vascular disruption agents and uses thereof
03/12/2014EP2704715A2 Tolerogenic synthetic nanocarriers for generating cd8+regulatory t cells
03/12/2014EP2704714A2 Tolerogenic synthetic nanocarriers to reduce cytotoxic t lymphocyte responses
03/12/2014EP2704700A1 Selecting use of proteasome inhibitors based on nf-kb2 sequence
03/12/2014EP2704699A1 Methods for treating prostate cancer
03/12/2014EP2704690A1 Hydrophobic preparations
03/12/2014EP2704688A1 Cochleate compositions and methods of making and using same
03/12/2014CN103635489A Plasma kallikrein binding proteins
03/12/2014CN103635488A Anti-CD40 antibodies and methods of use
03/12/2014CN103635487A Selective elimination of erosive cells
03/12/2014CN103635486A HLA-restricted, peptide-specific antigen binding proteins
03/12/2014CN103635204A CETP fragments
03/12/2014CN103627678A Porcine pseudorabies virus (PRV) variant PRV-ZJ01 and application thereof
03/12/2014CN103627667A Preparation method of lactococcus lactis engineering bacteria for secretory expression of peanut allergens and application thereof
03/12/2014CN103627005A Polyethylene glycol modified polyethyleneimine and use of polyethylene glycol modified polyethyleneimine as antigen protein vector
03/12/2014CN103626878A Newcastle disease virus F protein and enterotoxin LTB fusion protein and application thereof
03/12/2014CN103626877A NY-ESO-1-containing fusion protein as well as preparation method and application thereof
03/12/2014CN103626871A Monoclonal antibodies capable of specifically recognizing EGFR mutant protein, preparation method and application thereof
03/12/2014CN103626869A Method for preparing sheep myostatin (MSTN) gene monoclonal antibody vaccines
03/12/2014CN103626862A Recombinant lactococcus lactis cocci of expression modified dust mite allergen XDerp2 and application
03/12/2014CN103626860A Lactococcus lactis recombinant bacteria for expressing hypoallergenic peanut allergen, and application thereof
03/12/2014CN103623428A Transformation method and application of recombinant virus containing ER beta
03/12/2014CN103623408A Low dose methods for treating disorders in which tnf dollar g(a) activity is detrimental
03/12/2014CN103623405A Polysaccharide-protein conjugate vaccines
03/12/2014CN103623404A Haemophilus influenzac type B polysaccharide conjugate vaccine preparation method
03/12/2014CN103623403A Vaccine composition for resisting swine fever virus and porcine circovirus 2 infection, and preparation and application thereof
03/12/2014CN103623402A Preparation method of porcine circovirus type 2 inactivated vaccine
03/12/2014CN103623401A Multivalent pneumococcus capsular polysaccharide-protein conjugated composition and preparation method thereof
03/12/2014CN103623400A Vaccine composition for resisting pig mycoplasma pneumonia and infectious pleuropneumonia and preparation method
03/12/2014CN103623399A Method for preparing and identifying recombinant bifidobacterium vaccine of taenia solium TSO45W-4B gene
03/12/2014CN103623398A Method for preparing and identifying recombinant bifidobacterium vaccine of taenia solium TSO45W-4B-TSOL18 fusion gene
03/12/2014CN103623397A Method for preparing and identifying recombinant bifidobacterium vaccine of taenia solium TSOL18 gene
03/12/2014CN103159859B Sendai virus antigen peptide composition and application thereof in detecting Sendai virus infection
03/12/2014CN103087198B MRSA (Methicillin Resistant Staphylococcus Aureus) vaccine recombinant protein antigen I1C and preparation method and application thereof
03/12/2014CN102977214B Recombinant protein HF2 used for methicillin-resistant staphylococcus aureus (MRSA) vaccine, and preparation method and application thereof
03/12/2014CN102895677B Multivalent carrier vaccine for shrimp and application thereof
03/12/2014CN102851256B In vitro culture method for promoting maturation of dendritic cells and special culture medium for same
03/12/2014CN102793927B Swine fever vaccine heat-resistant freeze-drying protective agent, and preparation method and application thereof
03/12/2014CN102793920B Compound immunopotentiator, inactivated vaccine for poultry, and preparation method thereof
03/12/2014CN102741272B Peptides inhibiting adhesion of aspergillus fumigatus to cornea
03/12/2014CN102698264B Bursin-like polypeptide derivative applied as immuno-enhancer of compound hog cholera vaccines
03/12/2014CN102626422B Human sperm specific transfer factor oral preparation and preparation process thereof
03/12/2014CN102584947B Antibodies directed against hepatitis c virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions
03/12/2014CN102580118B Preparation method of shiga-like toxin Stx1B oral vaccine and product of shiga-like toxin Stx1B oral vaccine
03/12/2014CN102559636B Antibody fusion protein used for leukemia and autoimmune disease and preparation method thereof
03/12/2014CN102552901B Application of fullerene derivative to prepare gene transmission vector
03/12/2014CN102532312B Anti-Vibrio anguillarum yolk antibody, and preparation method, titer detection method and application thereof
03/12/2014CN102465137B Pichia pastoris for expressing rotavirus expression particles as well as preparation method and application of pichia pastoris
03/12/2014CN102311957B Hydatidovis soluble antigen preparation method and product thereof
03/12/2014CN102266555B Method for preparing grass carp reovirus (GCRV) gene engineering vaccines
03/12/2014CN102224237B Bacterial ghost (BG) production process using beta-propiolactone (BLP) for final inactivation
03/12/2014CN102178951B Method for producing intravenous injection human immune globulin
1 ... 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 ... 1823